| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |